Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion
Go back to Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion| Danaher Corp. (NYSE: DHR) | Delayed: 178.97 +0.78 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $178.19 | 52 Week High | $102.79 | |||
| Open | $179.07 | 52 Week Low | $75.71 | |||
| Day High | $181.71 | P/E | 47.10 | |||
| Day Low | $177.07 | EPS | $3.80 | |||
| Volume | 4,149,961 | |||||
| General Electric (NYSE: GE) | Delayed: 356.47 +1.35 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $355.12 | 52 Week High | $33.00 | |||
| Open | $349.28 | 52 Week Low | $27.10 | |||
| Day High | $359.92 | P/E | 242.50 | |||
| Day Low | $347.77 | EPS | $1.47 | |||
| Volume | 4,735,225 | |||||
